Guide: Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm (European Union)
From Beacon
Go back to European Union page
Primary purpose: To provide guidance to policy-makers and public health leads in the WHO European Region on planning, designing, and implementing effective screening programs while considering evidence-based decision-making, quality assurance, and minimizing potential harm, costs, and burdens on the healthcare system.
Sponsor, manager or home institution: WHO Regional Office for Europe.
Type of information: screening.
Data level: european level.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Access to information: Click here to access.
Categories:
- Forpolicymakers
- Mouth
- Throat
- Oropharynx
- Nasopharynx
- Hypopharynx
- Larynx
- Salivary glands
- Lips
- Tonsils
- Base of the tongue
- Voice box
- Esophagus
- Stomach
- Small intestine
- Large intestine
- Colon
- Rectum
- Anus
- Liver
- Gallbladder
- Bile ducts
- Pancreas
- Lung
- Trachea
- Bronchi
- Pleura
- Mediastinum
- Bone
- Cartilage
- Osteosarcoma
- Ewings sarcoma
- Skin
- Melanoma
- Scalp
- Hands
- Feet
- Muscle
- Fat
- Tendon
- Ligament
- Blood vessels
- Connective tissue
- Sarcoma
- Angiosarcoma
- Liposarcoma
- Lobular
- Breast
- Nipple
- Areola
- Ductal
- Vulva
- Vagina
- Cervix
- Uterus
- Ovary
- Fallopian tubes
- Endometrium
- Prostate
- Testicles
- Penis
- Kidney
- Ureter
- Bladder
- Urethra
- Eye
- Brain
- Spinal cord
- Thyroid gland
- Parathyroid
- Adrenal glands
- Pituitary gland
- Thymus gland
- Peritoneum
- Pericardium
- Retroperitoneum
- Mesothelium
- Blood
- Bone marrow
- Lymph nodes
- Spleen
- Leukemia
